Follow
HAYRETTİN TONBUL
HAYRETTİN TONBUL
Verified email at inonu.edu.tr
Title
Cited by
Cited by
Year
Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer
H Tonbul, A Sahin, E Tavukcuoglu, G Esendagli, Y Capan
Journal of Drug Delivery Science and Technology 54, 101380, 2019
382019
Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells
H Tonbul, A Sahin, E Tavukcuoglu, G Ultav, S Akbas, Y Aktas, ...
Journal of Drug Delivery Science and Technology 63, 102535, 2021
232021
Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier
I Seko, H Tonbul, E Tavukçuoğlu, A Şahin, S Akbas, H Yanık, SC Öztürk, ...
Journal of Drug Delivery Science and Technology 66, 102867, 2021
132021
Brain-targeted nanoparticles to overcome the blood-brain barrier
S Indrit, A Şahin, H Tonbul, Y Çapan
Journal of Pharmaceutical Technology 1 (1), 25-39, 2020
102020
Independent predictive factors for the persistence and tolerance of cow's milk allergy
E Topal, MH Çeliksoy, M Arga, MS Kaynak, Y Duman, S Demirtaş, ...
International Forum of Allergy & Rhinology 9 (1), 67-71, 2019
102019
pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)
G Ultav, H Tonbul, E Tavukcuoglu, SC Ozturk, S Akbas, A Sahin, ...
Journal of Nanoparticle Research 24 (2), 40, 2022
52022
Development of paclitaxel and flurbiprofen coloaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett–Burman design
A Sahin, S Caban-Toktas, H Tonbul, F Yerlikaya, Y Aktas, Y Capan
Istanbul Journal of Pharmacy 49 (3), 161-166, 2019
52019
Synthesis of small-sized mesoporous silica nanoparticles by experimental design and characterization for further drug delivery
H Tonbul, G Ultav, S AKBAŞ, A Sahin, Y AKTAŞ, Y Capan
Latin American Journal of Pharmacy 38 (11), 2019
52019
An effective VEGF-siRNA delivery via folic acid decorated and pegylated silica nanoparticles
G Ultav, H Tonbul, E Salva
Journal of Drug Delivery Science and Technology 76, 103828, 2022
42022
Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods
Y Çapan, A Sahin, H Tonbul
CRC Press, 2021
32021
Overcoming the challenges of drug resistance through combination drug delivery approach
H Tonbul, A Şahin, Y Çapan
Combination Drug Delivery Approach as an Effective Therapy for Various …, 2022
22022
Evaluation of Targeted Mesoporous Silica Nanoparticles
H Tonbul
Drug Delivery with Targeted Nanoparticles, 643-656, 2021
22021
Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications
H Tonbul, Y Çapan
Poly (lactic-co-glycolic acid)(PLGA) Nanoparticles for Drug Delivery, 417-431, 2023
12023
Silica nanoparticle synthesis by experimental design for drug and gene delivery applications
G Ultav, H TONBUL, A ŞAHİN, Y ÇAPAN
Journal of research in pharmacy (online) 27 (1), 2023
12023
Demographics and clinical characteristic of patients diagnosed with hen’s egg allergy
E Topal, M Arga, MH Celiksoy, MS Kaynak, Y Duman, S Demirtas, ...
12019
Development of Silica Nanoparticles as a Delivery System for Plasmid-Based Crispr/Cas9
G ULTAV, MAC Kubra, S KİZİLBOGA, V GUNDOGDU, H TONBUL, ...
Anatolian Journal of Pharmaceutical Sciences 1 (1), 33-39, 2022
2022
An effective VEGF-siRNA delivery via folic acid decorated and pegylated
G Ultav, H Tonbul, E Salva
2022
pH-sensitive chitosan-PEG-decorated hollow mesoporous silica
G Ultav, H Tonbul, E Tavukcuoglu, SC Ozturk, S Akbas, A Sahin, ...
2022
Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines
HC Çetintaş, H Tonbul, A Şahin, Y Çapan
Drug Delivery with Targeted Nanoparticles, 725-741, 2021
2021
Characteristics of Marketed Nanopharmaceutics
E Şalva, H Tonbul
Drug Delivery with Targeted Nanoparticles, 705-724, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20